论文部分内容阅读
目的探讨氧气驱动雾化吸入(oxygen atomizing inhalation,OAI)治疗小儿喘憋性肺炎(pediatrics asthmatic pneumonia,PAP)的临床疗效。方法 74例PAP患儿采用随机数字表法分为对照组38例和观察组36例。对照组给予常规抗生素控制感染、抗病毒、化痰、平喘等对症治疗。观察组在对照组基础上加用OAI,观察二组患儿临床疗效有无差异。结果观察组患儿气喘、咳嗽、肺部啰音等临床症状持续时间及住院时间明显短于对照组(P<0.05);治疗1周后观察组患儿的总有效率97.2%明显高于对照组81.6%(P<0.05)。结论 OAI可快速缓解患儿症状,提高疗效,缩短住院时间。
Objective To investigate the clinical efficacy of oxygen atomizing inhalation (OAI) in the treatment of pediatrics asthmatic pneumonia (PAP). Methods 74 children with PAP were divided into control group (n = 38) and observation group (n = 36) by random number table. Control group given conventional antibiotics to control infection, anti-virus, phlegm, asthma and other symptomatic treatment. The observation group added OAI on the basis of the control group to observe whether there was any difference between the two groups in clinical efficacy. Results The duration of the clinical symptoms and hospital stay of the observation group were significantly shorter than those of the control group (P <0.05). The total effective rate of the observation group was significantly higher than that of the control group Group 81.6% (P <0.05). Conclusion OAI can quickly relieve the symptoms of children, improve the curative effect and shorten the hospitalization time.